Korean Pharmaceutical and Bio-Pharma Association Explores Exchanges and Workforce Training Cooperation with Irish Industry
Yongwon Ko Senior Reporter
yongwonko@yahoo.com | 2026-11-16 10:23:55
The Korea Pharmaceutical and Bio-Pharma Association (KPBMA) announced on the 16th that its delegation visited major biopharmaceutical institutions in Dublin, Ireland, on the 12th (local time) to discuss ways to expand bilateral industrial exchanges and strengthen cooperation in global bio-workforce training.
This visit was organized in conjunction with the association's participation in BIO Europe 2026. Led by Chairman Noh Yeon-hong, the delegation visited the National Institute for Bioprocessing Research and Training (NIBRT), IDA Ireland (the Irish government agency responsible for foreign direct investment), and SK biotek Ireland (operating as SK pharmteco's active pharmaceutical ingredient manufacturing facility in Ireland).
During a meeting on the 12th with Darrin Morrissey, CEO of NIBRT, Chairman Noh discussed future collaborative tasks, including the development of training programs reflecting industrial demands, expert exchanges, and AI-based education. They also explored ways to expand international cooperation in connection with the Global Training Hub for Biomanufacturing (GTH-B), which was launched after the World Health Organization (WHO) designated South Korea as a global bio-workforce training hub. The meeting was attended by Kang Joo-yeon, the South Korean Ambassador to Ireland.
KPBMA has been deepening its cooperation with NIBRT since 2019, driving collaboration among government, industry, and academia, and laying the groundwork for the establishment of the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) through local delegation visits.
Launched in 2021, K-NIBRT has built Good Manufacturing Practice (GMP)-based educational infrastructure to train job seekers and industry incumbents, with 3,308 individuals completing its programs last year. Furthermore, it has earned NIBRT global partner accreditation in antibody and cell and gene therapy (CGT) bioprocess training. K-NIBRT also participates as a domestic network campus in the GTH-B project, an initiative designated by the WHO to strengthen vaccine and biopharmaceutical manufacturing capabilities in low- and middle-income countries.
The KPBMA delegation also held a meeting with Rachel Shelly, Global Head of Life Sciences at IDA Ireland. Both sides discussed ways to promote Ireland’s strategic hub value to the domestic industry and leverage IDA Ireland’s network of global pharmaceutical and biotech companies to foster bilateral corporate cooperation. Following the meeting, the delegation visited SK pharmteco’s API production facility to examine a Korean company's overseas production base operation case and strategies for entering the European market, while exploring ways to raise the domestic API self-sufficiency rate and the role of Korean manufacturers in global supply chains.
Chairman Noh Yeon-hong stated, "Ireland has established itself as a major European biopharmaceutical hub based on its superior industrial infrastructure and professional workforce. Taking this visit as an opportunity, we will expand exchanges between the two industries and broaden opportunities for domestic companies to enter the European market and collaborate on global business."
He added, "The cooperative experience accumulated by South Korea and Ireland during the establishment of K-NIBRT has served as a crucial foundation for building a domestic biopharmaceutical professional training infrastructure. Moving forward, based on both nations' educational capabilities and expertise, we hope to expand the scope of cooperation—particularly contributing to strengthening the vaccine and biopharmaceutical production capacities of low- and middle-income countries through joint curriculum development and professional exchanges linked with GTH-B."
Darrin Morrissey, CEO of NIBRT, remarked, "NIBRT’s cooperation with Korea is a prime example of the value that international partnerships can create in bioprocessing workforce training. We look forward to further expanding our collaboration in advanced bioprocessing education and global workforce development based on the educational foundation we have built together with K-NIBRT."
[ⓒ Global Economic Times. 무단전재-재배포 금지]
WEEKLY HOT
- 1Digital Footprints as Crime: Japanese Court Sentences Woman for Repeated Social Media "Likes" on Ex-Partner’s Profile
- 2Behind the Persona: Biographer Exposes the 'Real' Jensen Huang
- 3US Aviation Authorities Under Fire After Friday Afternoon Equipment Upgrade Triggers Widespread Flight Groundings Despite Warnings
- 4Parnas Hotel Posts Record-Breaking Q3 Operating Profit of 41.9 Billion Won
- 5Korea McNulty Posts 15% Increase in Q3 Sales and Turns to Operating Profit
- 6Korean Pharmaceutical and Bio-Pharma Association Explores Exchanges and Workforce Training Cooperation with Irish Industry